Immunogenicity assay of the Leishmune(®) vaccine against canine visceral leishmaniasis in Brazil

Leishmune(®) is the industrialized version of the FML-saponin vaccine which has been shown to develop 92–95% protection in vaccinated dogs and 76–80% vaccine efficacy against field canine visceral leishmaniasis (CVL) in Brazil. Leishmune(®) has been proven to be safe and tolerable and a transmission...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Vaccine
Main Authors: Borja-Cabrera, G.P., Santos, F.N., Bauer, F.S., Parra, L.E., Menz, I., Morgado, A.A., Soares, I.S., Batista, L.M.M., Palatnik-de-Sousa, C.B.
Format: Artigo
Jezik:Inglês
Izdano: Elsevier Ltd. 2008
Teme:
Short Communication
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7173152/
https://ncbi.nlm.nih.gov/pubmed/18675868
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2008.07.029
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki